FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

33692711000001103: Ibrance 100mg capsules (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Jan 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
102390001000001112 Ibrance 100mg capsules (Pfizer Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
102390101000001113 Ibrance 100mg capsules (Pfizer Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ibrance 100mg capsules (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ibrance 100mg capsules (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ibrance 100mg capsules (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Ibrance 100mg capsules (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Ibrance 100mg capsules (Pfizer Ltd) Is a Palbociclib 100mg capsules true Inferred relationship Existential restriction modifier
Ibrance 100mg capsules (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ibrance 100mg capsules (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ibrance 100mg capsules (Pfizer Ltd) Has specific active ingredient Palbociclib true Inferred relationship Existential restriction modifier
Ibrance 100mg capsules (Pfizer Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Ibrance 100mg capsules (Pfizer Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Ibrance 100mg capsules (Pfizer Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Ibrance 100mg capsules (Pfizer Ltd) Is a Ibrance true Inferred relationship Existential restriction modifier
Ibrance 100mg capsules (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ibrance 100mg capsules (Pfizer Ltd) Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Ibrance 100mg capsules (Pfizer Ltd) Has active ingredient Substance with protein kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ibrance 100mg capsules (Pfizer Ltd) 63 capsule 9 x 7 capsules Has AMP True Ibrance 100mg capsules (Pfizer Ltd) Inferred relationship Existential restriction modifier
Ibrance 100mg capsules (Pfizer Ltd) 21 capsule 3 x 7 capsules Has AMP True Ibrance 100mg capsules (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start